Numinus Congratulates MAPS on Phase 3 Clinical Trial Demonstrating Significant Benefits of MDMA-Assisted Therapy for Severe PTSD Cannabis Investing News
Seelos Therapeutics to Participate in the 2021 Jefferies Virtual Healthcare Conference Psychedelics Investing
COMPASS Pathways plc to announce first quarter 2021 financial results on 13 May 2021 Psychedelics Investing
MindMed Announces Project Angie, Targeting the Treatment of Pain with Psychedelics Psychedelics Investing
Braxia Scientific Introduces "Braxia Health" a Growing Network of Clinics Leading Novel Psychedelic Research and Treatments for Mental Disorders Psychedelics Investing
SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Champignon Brands Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Psychedelics Investing
Optimi Health Partnership with Numinus Wellness Provides Update on First All-Natural Psilocybin Protocol Cannabis Investing News
